The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Income (loss) from continuing operations | -17 | -1,035 | -51 | 122 |
| Depreciation and amortization | 237 | 240 | 237 | 257 |
| Deferred income taxes | 29 | 192 | 50 | -23 |
| Stock compensation | 10 | 37 | 35 | 35 |
| Goodwill impairments | - | 485 | - | - |
| Indefinite-lived asset impairments | - | 290 | - | - |
| Other long-lived asset impairments | - | 27 | - | - |
| Net periodic pension and other postretirement costs | -4 | -8 | -8 | -8 |
| Gain on early extinguishment of debt | - | 16 | - | - |
| Other long-lived asset impairments | -2 | - | 0 | 2 |
| Noncash Income Expense | -13 | -8 | -2 | -14 |
| Accounts receivable, net | -152 | 88 | 4 | 66 |
| Inventories | 95 | -241 | 81 | 157 |
| Prepaid expenses and other current assets | -2 | -104 | 42 | -34 |
| Accounts payable | 102 | 39 | -57 | 5 |
| Accrued expenses and other current liabilities | 203 | 180 | -182 | 8 |
| Operating Activities Cash Flow Statement | -13 | -14 | -26 | 10 |
| Cash flows from (used in) operations - continuing operations | 213 | 596 | 237 | 217 |
| Cash flows from (used in) operations - discontinued operations | 0 | -12 | 0 | 0 |
| Cash flows from (used in) operations | 213 | 584 | 237 | 217 |
| Capital expenditures | 137 | 140 | 111 | 140 |
| Acquisitions of developed technology and investments | - | 0 | 0 | 9 |
| Proceeds from sale of marketable equity securities | - | 0 | 0 | 0 |
| Other investing activities, net | -4 | -26 | 0 | -34 |
| Cash flows from (used in) investing activities - continuing operations | -133 | -114 | -111 | -115 |
| Cash flows from (used in) investing activities - discontinued operations | 0 | -84 | 0 | 0 |
| Cash flows from (used in) investing activities | -133 | -198 | -111 | -115 |
| Issuances of debt | - | 1,998 | - | - |
| Increase in short term debt | - | 0 | - | - |
| Repayments of debt | 0 | 1,984 | 0 | 680 |
| Repayments of debt with original maturities of three months or less | 0 | 0 | 0 | 0 |
| Cash dividends on common stock | 5 | 87 | 87 | 87 |
| Proceeds from stock issued under employee benefit plans | 8 | 5 | 9 | 6 |
| Payments of contingent liabilities | - | 40 | 10 | - |
| Other financing activities, net | -14 | -39 | 7 | -1 |
| Cash flows from (used in) financing activities | -11 | -147 | -81 | -762 |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash - continuing operations | -20 | - | -50 | 52 |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | - | 84 | 0 | - |
| Increase (decrease) in cash, cash equivalents and restricted cash | 51 | 240 | 40 | -608 |
| Cash, cash equivalents and restricted cash at start of period | 1,968 | 0 | 0 | 2,414 |
| Cash, cash equivalents and restricted cash at end of period | 2,019 | 1,968 | 1,728 | 1,688 |
| Less cash and cash equivalents of discontinued operations | 0 | - | - | - |
| Cash, cash equivalents and restricted cash | 2,019 | - | - | - |
BAXTER INTERNATIONAL INC (BAX)
BAXTER INTERNATIONAL INC (BAX)